Sunzen Biotech Bhd Cash Flow Quality Index
Sunzen Biotech Bhd cash flow quality index. Sunzen Biotech Bhd (0148) has a Cash Flow Quality Index of 2.11x as of September 2023. Operating cash flow of RM3.58 Million exceeds net income of RM1.69 Million, indicating high earnings quality where cash backs reported profits. See 0148 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sunzen Biotech Bhd (2017–2023)
Cash flow quality index of Sunzen Biotech Bhd from 2017 to 2023. Historical Cash Flow Quality Index for Sunzen Biotech Bhd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Sunzen Biotech Bhd to assess how comfortably operating cash covers total debt obligations.
Sunzen Biotech Bhd Cash Flow Quality Index by Year (2017–2023)
Sunzen Biotech Bhd cash flow quality index by year from 2017 to 2023. Year-by-year earnings quality comparison for Sunzen Biotech Bhd. For the full cash flow conversion analysis, see Sunzen Biotech Bhd (0148) cash conversion ratio.
| Year | Quality Index | Operating CF (MYR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.12x | RM819.39K | RM6.80 Million | ▲ +101.4% |
| 2022 | -8.55x | RM-32.06 Million | RM3.75 Million | ▲ +64.4% |
| 2021 | -24.05x | RM-16.36 Million | RM680.13K | ▼ -2500.6% |
| 2017 | 1.00x | RM4.02 Million | RM4.01 Million | — |